These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 15548377

  • 1. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E.
    Biochem Pharmacol; 2004 Dec 15; 68(12):2301-15. PubMed ID: 15548377
    [Abstract] [Full Text] [Related]

  • 2. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E.
    Med Res Rev; 2005 Jan 15; 25(1):1-20. PubMed ID: 15389733
    [Abstract] [Full Text] [Related]

  • 3. The development of BVDU: An odyssey.
    De Clercq E.
    Antivir Chem Chemother; 2023 Jan 15; 31():20402066231152971. PubMed ID: 36710501
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C, Cool V, Baudson N, Degrève B, Balzarini J, De Leval L, Debrus S, Velu T, Calberg-Bacq CM.
    Cancer Gene Ther; 2000 Feb 15; 7(2):215-23. PubMed ID: 10770629
    [Abstract] [Full Text] [Related]

  • 5. Potential of bromovinyldeoxyuridine in anticancer chemotherapy.
    De Clercq E.
    Anticancer Res; 1986 Feb 15; 6(4):549-56. PubMed ID: 3752935
    [Abstract] [Full Text] [Related]

  • 6. Brivudin (bromovinyl deoxyuridine).
    Keam SJ, Chapman TM, Figgitt DP.
    Drugs; 2004 Feb 15; 64(18):2091-7; discussion 2098-9. PubMed ID: 15341504
    [Abstract] [Full Text] [Related]

  • 7. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
    De C, Liu D, Zheng B, Singh US, Chavre S, White C, Arnold RD, Hagen FK, Chu CK, Moffat JF.
    Antiviral Res; 2014 Oct 15; 110():10-9. PubMed ID: 25051026
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E, Descamps J, Ogata M, Shigeta S.
    Antimicrob Agents Chemother; 1982 Jan 15; 21(1):33-8. PubMed ID: 6282207
    [Abstract] [Full Text] [Related]

  • 9. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study.
    Wassilew SW, Wutzler P, Brivddin Herpes Zoster Study Group.
    Antiviral Res; 2003 Jun 15; 59(1):49-56. PubMed ID: 12834860
    [Abstract] [Full Text] [Related]

  • 10. [5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
    Wutzler P, Wutke K, Bärwolff D, Reefschläger J.
    Z Gesamte Inn Med; 1988 Dec 01; 43(23):677-80. PubMed ID: 2854331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J, De Clercq E, Baumgartner H, Bodenteich M, Griengl H.
    Mol Pharmacol; 1990 Mar 01; 37(3):395-401. PubMed ID: 2156153
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M, Suzutani T, Mizuta K, Kurane I, Morikawa S.
    Arch Virol; 2008 Mar 01; 153(2):303-14. PubMed ID: 18066636
    [Abstract] [Full Text] [Related]

  • 20. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
    Wildiers J, De Clercq E.
    Eur J Cancer Clin Oncol; 1984 Apr 01; 20(4):471-6. PubMed ID: 6539202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.